SpringWorks lands FDA approval for nerve tumor treatment
SpringWorks Therapeutics, a biotech potentially on the verge of being acquired, won its second FDA approval.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
